How is liver transplant in case of PBC?

Best therapy for end-stage disease, used w/development of major complications of portal HTN, but have poor QoL due to disabling fatigue, intractable pruritis and severe muscle wasting. We may have persistent increase in serum Bi w/out hepatic malignancy, 1-year survival >90%, 5-year survival >80%, AMA may persist after transplant.